Day: May 20, 2021

Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing

Staff May 20, 2021

Proceeds will be Used to Accelerate Advancement of Pipeline of Multispecific Antibodies in Oncology WAEDENSWIL, Switzerland--(BUSINESS WIRE)--Numab Therapeutics AG, a...

Neural Therapeutics Undertakes Multiple Initiatives to Defer and Eliminate a Significant Portion of Financial Obligations

Staff November 25, 2024

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Staff November 25, 2024

Delivra Health Brands and its Leading Brands Dream Water (R) and LivRelief(TM) Report Financial Results for First Quarter of Fiscal 2025

Staff November 25, 2024

BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors

Staff November 25, 2024

Edison Issues Report on Care REIT (CRT)

Staff November 25, 2024

Numab Therapeutics Completes Oversubscribed CHF 100 Million Series C Financing

You may have missed

Neural Therapeutics Undertakes Multiple Initiatives to Defer and Eliminate a Significant Portion of Financial Obligations

Psyched Wellness Announces Appointment of New Director and Resignation of a Director

Delivra Health Brands and its Leading Brands Dream Water (R) and LivRelief(TM) Report Financial Results for First Quarter of Fiscal 2025

BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors

Edison Issues Report on Care REIT (CRT)